Тошкент педиатрия тиббиёт институти

Implementation of research results. 
Based on the research results obtained: 
received Patent No. IAP 05345 for an invention in the Intellectual Property 
Agency dated 08.02.2017 under the name "Composition of ingredients for 
medicinal syrup with antianemic and anti-inflammatory action." This invention 
allows it to be expediently used for the primary prevention and treatment of non-
severe forms of iron deficiency - mild and moderate LDL and IDA; 
based on the results of the study of clinical laboratory and early prevention, 
the methodological recommendation "Method of using Bioferron for iron 
deficiency anemia in adolescent girls" was approved (approved by the Ministry of 
Health of the Republic of Uzbekistan No. 8n-r / 542 dated November 27, 2019). 
This methodological recommendation allowed for early prevention and proved the 

---

50 
effectiveness of the drug "Bioferron" in a comparative aspect with the drug 
"Ferrum-Lek" on the basis of a dynamic study of peripheral blood parameters; 
Scientific developments to improve early prevention and improve treatment 
based on the clinical and laboratory characteristics of adolescent girls with LHD 
and IDA have been introduced into the practical activities of the Andijan Regional 
Multidisciplinary Central Polyclinic and the Andijan Regional Children's 
Multidisciplinary Medical Center (conclusion of the Ministry of Health of the 
Republic of Uzbekistan, September 18, 2020, No. 8n -d / 132). 
As a result of the use of the proposed method of treatment and the algorithm 
for predicting complications, the economic efficiency increased due to the 
improvement of the quality of medical care, a decrease in the risk of developing 
various complications in LHD and mild manifest forms of IDA in adolescent girls, 
a decrease in disability, mortality, an increase in the duration of remission of the 
disease, and an improvement in quality. life of patients, reduction of inpatient 
treatment by four bed-days and cost savings per year. 
The practical significance of the research results lies in the early prevention of 
complications of the disease, increasing the effectiveness of therapy, shortening the 
duration of inpatient treatment and improving the quality of life of patients through 
the development of a "Method for improving iron deficiency in adolescence", 
which presents an approximate scheme for the treatment and prevention of iron 
deficiency, taking into account the stages and dynamics , the results of observation 
of adolescent girls and proved the effectiveness of the drug "Bioferron" in a 
comparative aspect with the drug "Ferrum-Lek" on the basis of a dynamic study of 
peripheral blood parameters.